• Empower your research with Pharmidex, a leading CRO offering advanced solutions in Bioanalysis (GLP/GCP), CNS, DMPK, Oncology, Immunology, Respiratory, and Toxicology (GLP).

    Slide title

    Empower your research with Pharmidex, a leading CRO offering advanced solutions in Bioanalysis (GLP/GCP), CNS, DMPK, Oncology, Immunology, Respiratory, and Toxicology (GLP).

    Button
  • Unlock the full potential of your research with Pharmidex, your trusted partner in drug discovery, offering unparalleled expertise and innovative solutions to drive your projects toward success.

    Slide title

    Unlock the full potential of your research with Pharmidex, your trusted partner in drug discovery, offering unparalleled expertise and innovative solutions to drive your projects toward success.

    Button

Service Offerings


Therapeutic Areas

Services By Developmental Phase

Latest News

Who We Are

About us

Pharmidex is a contract research organisation (CRO) that provides translational solutions using its world-renowned expertise in CNS, oncology, respiratory, DMPK, drug discovery and ADMET/pharmacokinetics.


Founded in the UK, in 2002, Pharmidex operates in state-of-the-art facilities in Hertfordshire to provide high-quality experimental data and expert guidance to support drug discovery and development.

Home

Key Facts

Experts in therapeutic preclinical models 


Accredited by AAALAC and the MHRA to perform GLP and GCP certified services

Home

Services

Single site service offering with 15,000+ studies conducted to date


Quick turnaround times, cost effective research, expert interpretation and customer-focused approach

Home

Our History

Successfully helped multiple clients reach clinical development since 2002

News

DMPK Services News! More News!
Pharmidex attending DMDG 51st Open Meeting 2025.
September 1, 2025
We’re delighted to share that Martin Barrett , our Head of Business Development, and Rob Jenkins , our Bioanalytical Scientist, will be attending the 51st Open Meeting 2025. This event is a fantastic opportunity to connect with industry leaders, share insights and build new collaborations. Martin and Rob are looking forward to meeting fellow attendees, exchanging ideas and exploring ways to create impactful partnerships that advance drug discovery and development. 🤝 If you’re attending, don’t hesitate to reach out they’ll be happy to connect, discuss your projects, and explore potential synergies.
Pharmidex help drug developers hit their IND submission dates
September 1, 2025
Designing robust preclinical studies that deliver accurate data the first time. Building flexibility into plans to prevent delays when priorities shift. Coordinating ADME, PK/PD, and toxicology in parallel to save weeks. With over 16,000 projects conducted successfully, work with a proven partner from early discovery to regulatory submission. Our tailored, quality-driven approach keeps your programme on track and your milestones within reach. Let’s make your IND deadline a milestone you hit with confidence
Welcome to Pharmidex
August 26, 2025
We’re delighted to welcome two new colleagues to the Pharmidex team: 👨‍🔬 Shaani Ahmed , joining us as a DMPK Junior Scientist, will be supporting our in vitro and in vivo ADME studies, helping us continue to deliver high-quality results for our clients. 👩‍🔬 Ruby Lambert , our new Junior Bioanalyst, will be working alongside the Bioanalysis team to support projects and contribute to the scientific insights that drive our mission forward. Both Shaani and Ruby bring fresh energy and enthusiasm to Pharmidex , and we’re excited to support their growth in our collaborative environment. Please join us in giving them both a very warm welcome to the Pharmidex family! 💜💚
Services by Department